Live feed
Filing
SC 13G/A
SC 13G/A0001493152-24-005666·Eton Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
Fixed Income Clearing Corp.
Security class unavailable · CUSIP: 000000000
Event date: 2023-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,524,887
- Percent of class
- 9.8400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-24-005666
- Form type
- SC 13G/A
- Filer
- Eton Pharmaceuticals, Inc.
- CIK
- CIK 1710340
- Filed
- Feb 09, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership